Novo Nordisk oral diabetes drug outperforms Lilly rival

The company ' s oral diabetes drug semaglutide was found to be better at lowering blood sugar levels than Jardiance from Eli Lilly and Boehringer Ingelheim
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news